Partnership to leverage the Helix Laboratory Platform and QIAGEN's biopharma relationships, NGS capabilities, and global regulatory expertise
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
Acquisitions have the potential to add at least $1 billion in sales by 2028
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
Mock drills are being conducted across the country to review the preparedness for management of COVID-19
WHO made a strong recommendation for nirmatrelvir and ritonavir for mild and moderate COVID-19 patients at highest risk of hospital admission
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Subscribe To Our Newsletter & Stay Updated
